SEARCH

SEARCH BY CITATION

References

  • Agdeppa, E.D., Kepe, V., Liu, J., Small, G.W., Huang, S.C., Petric, A., Satyamurthy, N. & Barrio, J.R. (2003) 2-Dialkylamino-6-acylmalononitrile substituted naphthalenes (DDNP analogs): novel diagnostic and therapeutic tools in Alzheimer’s disease. Mol. Imaging Biol., 5, 404417.
  • Ametamey, S.M., Kessler, L.J., Honer, M., Wyss, M.T., Buck, A., Hintermann, S., Auberson, Y.P., Gasparini, F. & Schubiger, P.A. (2006) Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5. J. Nucl. Med., 47, 698705.
  • Bacskai, B.J., Hickey, G.A., Skoch, J., Kajdasz, S.T., Wang, Y., Huang, G.F., Mathis, C.A., Klunk, W.E. & Hyman, B.T. (2003) Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice. Proc. Natl Acad. Sci. USA, 100, 1246212467.
  • Berger, A.B., Witte, M.D., Denault, J.B., Sadaghiani, A.M., Sexton, K.M., Salvesen, G.S. & Bogyo, M. (2006) Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes. Mol. Cell, 23, 509521.
  • Chen, Y.C.I., Galpern, W.R., Brownell, A.L., Matthews, R.T., Bogdanov, M., Isacson, O., Keltner, J.R., Beal, M.F., Rosen, B.R. & Jenkins, B.G. (1997) Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis and behavioural data. Magn. Reson. Med., 38, 389398.
  • Chen, Y.C.I., Choi, J.K., Andersen, S.L., Rosen, B.R. & Jenkins, B.G. (2005) Mapping dopamine D2/D3 receptor function using pharmacological magnetic resonance imaging. Psychopharmacology (Berl.), 180, 705715.
  • Farde, L., Wiesel, F.A., Halldin, C. & Sedvall, G. (1988) Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch. Gen. Psychiatry, 45, 7176.
  • Fields, S. & Song, O. (1989) A novel genetic system to detect protein-protein interactions. Nature, 340, 245246.
  • Foerster, T. (1948) Intermolecular energy migration and fluorescence. Ann. Phys. Leipzig, 2, 5575.
  • Gambhir, S.S. (2004) Quantitative assay development for PET. In Phelps, M.E. (ed.), PET – Molecular Imaging and Its Biological Applications. Springer-Verlag, New York, pp. 125216.
  • Gozzi, A., Large, C.H., Schwarz, A., Bertani, S., Crestan, V. & Bifone, A. (2008a) Differential effects of antipsychotic and glutamatergic agents on the phMRI response to phencyclidine. Neuropsychopharmacology, 33, 16901703.
  • Gozzi, A., Schwarz, A., Crestan, V. & Bifone, A. (2008b) Pharmacological manganese-enhanced MRI (MEMRI) without osmotic breakdown of the blood brain barrier. Proc. Intl. Soc. Mag. Reson. Med., 16, 2314.
  • Hamill, T.G., Krause, S., Ryan, C., Bonnefous, C., Govek, S., Seiders, T.J., Cosford, N.D., Roppe, J., Kamenecka, T., Patel, S., Gibson, R.E., Sanabria, S., Riffel, K., Eng, W., King, C., Yang, X., Green, M.D., O’Malley, S.S., Hargreaves, R. & Burns, H.D. (2005) Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers. Synapse, 56, 205216.
  • Harada, H., Kizaka-Kondoh, S., Itasaka, S., Shibuya, K., Morinibu, A., Shinomiya, K. & Hiraoka, M. (2007) The combination of hypoxia-response enhancers and an oxygen-dependent proteolytic motif enables real-time imaging of absolute HIF-1 activity in tumor xenografts. Biochem. Biophys. Res. Commun., 360, 791796.
  • Hintersteiner, M., Frey, P., Gremlich, H.U., Kinzy, W., Kneuer, R., Neumann, U., Rudin, M., Staufenbiel, M. & Wiederhold, K.H. (2005) In vivo detection of amyloid deposits by near-infrared fluorescence imaging using a novel oxazine derivative as contrast agent. Nat. Biotechnol., 23, 577583.
  • Hyde, D., DeKleine, R., MacLaurin, S.A., Miller, E., Brooks, D.H., Krucker, T. & Ntziachristos, V. (2009) Hybrid FMT-CT method for in vivo imaging of amyloid-β plaques in a murine model forAlzheimer’s disease. Neuroimage, 44, 13041311.
  • Hynynen, K. (2008) Ultrasound for drug and gene delivery to the brain. Adv. Drug Deliv. Rev., 60, 12091217.
  • Ishimaru, A. (1997) Wave Propagation and Scattering in Random Media. IEEE Press, New York.
  • Judenhofer, M.S., Wehrl, H.F., Newport, D.F., Catana, C., Siegel, S.B., Becker, M., Thielscher, A., Kneilling, M., Lichy, M.P., Eichner, M., Klingel, K., Reischl, G., Widmaier, S., Röcken, M., Nutt, R.E., Machulla, H.J., Uludag, K., Cherry, S.R., Claussen, C.D. & Pichler, B.J. (2008) Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat. Med., 14, 459465.
  • Klunk, W.E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D.P., Bergström, M., Savitcheva, I., Huang, G.F., Estrada, S., Ausén, B., Debnath, M.L., Barletta, J., Price, J.C., Sandell, J., Lopresti, B.J., Wall, A., Koivisto, P., Antoni, G., Mathis, C.A. & Långström, B. (2004) Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Ann. Neurol., 55, 306319.
  • Kudo, Y. (2006) Development of amyloid imaging PET probes for an early diagnosis of Alzheimer’s disease. Minim. Invasive Ther. Allied Technol., 15, 209213.
  • Kuhn, H. (1948) Qunatum mechanical theory of light absorption of organic dyes and similar compounds. J. Chem. Phys., 17, 11981212.
  • Lehmann, S., Stiehl, D.P., Honer, M., Dominietto, M., Keist, R., Kotevic, I., Wollenick, K., Ametamey, S., Wenger, R.H. & Rudin, M. (2009) Longitudinal and multimodal in vivo imaging of tumor hypoxia and its downstream molecular events. Proc. Natl Acad. Sci. USA, 106, 1400414009.
  • Lloyd, B., Sczcerba, D., Rudin, M. & Szekely, G. (2008) A computational framework for modelling solid tumour growth. Philos. Transact. A Math. Phys. Eng. Sci., 366, 33013318.
  • Logothetis, N.K. (2008) What we can do and what we cannot do with fMRI. Nature, 453, 869878.
  • Luker, G.D., Sharma, V., Pica, C.M., Dahlheimer, J.L., Li, W., Ochesky, J., Ryan, C.E., Piwnica-Worms, H. & Piwnica-Worms, D.L. (2002) Noninvasive imaging of protein-protein interactions in living animals. Proc. Natl Acad. Sci. USA, 99, 69616966.
  • Michnick, S.W. (2001) Exploring protein interactions by interaction-induced folding of proteins from complementary peptide fragments. Curr. Opin. Struct. Biol., 11, 472477.
  • Mueggler, T., Baumann, D., Rausch, M. & Rudin, M. (2001) Bicuculline-induced brain activation in mice detected by functional magnetic resonance imaging. Magn. Reson. Med., 46, 292298.
  • Ntziachristos, V., Ripoll, J., Wang, L.V. & Weissleder, R. (2005) Looking and listening to light: the evolution of whole-body photonic imaging. Nat. Biotechnol., 23, 313320.
  • Ogawa, S., Lee, T.M., Kay, A.R. & Tank, D.W. (1990) Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc. Natl Acad. Sci. USA, 87, 98689872.
  • Patel, S., Ndubizu, O., Hamill, T., Chaudhary, A., Burns, H.D., Hargreaves, R. & Gibson, R.E. (2005) Screening cascade and development of potential Positron Emission Tomography radiotracers for mGluR5: in vitro and in vivo characterization. Mol. Imaging Biol., 7, 314323.
  • Paulmurugan, R. & Gambhir, S.S. (2003) Monitoring protein-protein interactions using split synthetic Renilla luciferase protein-fragment-assisted complementation. Anal. Chem., 75, 15841589.
  • Paulmurugan, R., Umezawa, Y. & Gambhir, S.S. (2002) Noninvasive imaging of protein-protein interactions in living subjects by using reporter protein complementation and reconstitution strategies. Proc. Natl Acad. Sci. USA, 99, 1560815613.
  • Paulmurugan, R., Massoud, T., Huang, J. & Gambhir, S.S. (2004) Molecular imaging of drug-modulated protein-protein interactions in living subjects. Cancer Res., 64, 21132119.
  • Phelps, M.E. (2004) PET: Molecular Imaging and its Biological Applications. Springer, New York.
  • Rausch, M., Gentsch, C., Enz, A., Baumann, D. & Rudin, M. (2005) Characterization of CNS drugs by mapping changes in regional CBV in the rat: a study paradigm allowing for automated comparison of three-dimensional data obtained multiple imaging sessions. NMR Biomed., 18, 260268.
  • Ray, P., Pimenta, H., Paulmurugan, R., Berger, F., Phelps, M.E., Iyer, M. & Gambhir, S.S. (2002) Noninvasive quantitative imaging of protein-protein interactions in living subjects. Proc. Natl Acad. Sci. USA, 99, 31053110.
  • Reese, T., Bjelke, B., Porszasz, R., Baumann, D., Bochelen, D., Sauter, A. & Rudin, M. (2000) Regional brain activation by bicuculline visualized by functional magnetic resonance imaging: time-resolved assessment of bicuculline-induced changes in local cerebral blood volume using an intravascular contrast agent. NMR Biomed., 13, 4349.
  • Reese, T., Bochelen, D., Baumann, D., Rausch, M., Sauter, A. & Rudin, M. (2002) Impaired functionality of reperfused brain tissue following short transient focal ischemia in rats. Magn. Reson. Imaging, 20, 447454.
  • Rudin, M. (2005) Molecular imaging – Basic Principles and Applications in Biomedical Research. Imperial College Press, London.
  • Rudin, M. (2008) Noninvasive imaging of receptor function: signal transduction pathways and physiological readouts. Curr. Opin. Drug Discov. Devel., 11, 606615.
  • Rudin, M. & Weissleder, R. (2003) Molecular imaging in drug discovery and development. Nat. Rev. Drug Discov, 3, 123131.
  • Safran, M., Kim, W.Y., O’Connell, F., Flippin, L., Günzler, V., Horner, J.W., Depinho, R.A. & Kaelin, W.G. Jr (2006) Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production. Proc. Natl Acad. Sci. USA, 103, 105110.
  • Scanley, B.E., Kennan, R.P. & Gore, J.C. (2001) Changes in rat cerebral blood volume due to modulation of the 5-HT(1A) receptor measured with susceptibility enhanced contrast MRI. Brain Res., 913, 149155.
  • Schwarz, A.J., Zocchi, A., Reese, T., Gozzi, A., Garzotti, M., Varnier, G., Curcuruto, O., Sartori, I., Girlanda, E., Biscaro, B., Crestan, V., Bertani, S., Heidbreder, C. & Bifone, A. (2004) Concurrent pharmacological MRI and in situ microdialysis of cocaine reveal a complex relationship between the central hemodynamic response and local dopamine concentration. Neuroimage, 23, 296304.
  • Schwarz, A.J., Gozzi, A., Reese, T. & Bifone, A. (2007) In vivo mapping of functional connectivity in neurotransmitter systems using pharmacological MRI. Neuroimage, 34, 16271636.
  • Shaner, N.C., Steinbach, P.A. & Tsien, R.Y. (2005) A guide to choosing fluorescent proteins. Nat. Methods, 2, 905909.
  • Shoghi-Jadid, K., Small, G.W., Agdeppa, E.D., Kepe, V., Ercoli, L.M., Siddarth, P., Read, S., Satyamurthy, N., Petric, A., Huang, S.C. & Barrio, J.R. (2002) Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am. J. Geriatr. Psychiatry, 10, 2435.
  • Sigurdson, C.J., Nilsson, K.P., Hornemann, S., Manco, G., Polymenidou, M., Schwarz, P., Leclerc, M., Hammarström, P., Wüthrich, K. & Aguzzi, A. (2007) Prion strain discrimination using luminescent conjugated polymers. Nat. Methods, 4, 10231030.
  • Silverman, D.H.S. & Melega, W.P. (2004) Molecular imaging of biological processes with PET: evaluating biological bases of cerebral function. In Phelps, M.E. (ed.), PET – Molecular Imaging and Its Biological Applications. Springer-Verlag, New York, pp. 509583.
  • Slifstein, M. & Laruelle, M. (2001) Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers. Nucl. Med. Biol., 28, 595608.
  • Soto, C. & Estrada, L.D. (2008) Protein misfolding and neurodegeneration. Arch. Neurol., 65, 184189.
  • Tauscher, J. & Kapur, S. (2001) Choosing the right dose of antipsychotics in schizophrenia. CNS Drugs, 15, 671677.
  • Tung, C.H., Mahmood, U., Bredow, S. & Weissleder, R. (2000) In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res., 60, 49534958.
  • Verhoeff, N.P., Wilson, A.A., Takeshita, S., Trop, L., Hussey, D., Singh, K., Kung, H.F., Kung, M.P. & Houle, S. (2004) In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET. Am. J. Geriatr. Psychiatry, 12, 584595.
  • Watson, A., Wu, X. & Bruchez, M. (2003) Lighting up cells with qunatum dots. BioTechniques, 34, 296303.
  • Wise, R.G. & Tracey, I. (2006) The role of fMRI in drug discovery. J. Magn. Reson. Imaging, 23, 862876.
  • Yoffe, A.D. (2001) Semiconductor quantum dots and related systems: electronic, optical, luminescence and related properties of low dimensional systems. Adv. Phys., 50, 1208.
  • Yu, M., Tueckmantel, W., Wang, X., Zhu, A., Kozikowski, A.P. & Brownell, A.L. (2005a) Methoxyphenylethynyl, methoxypyridylethynyl and phenylethynyl derivatives of pyridine: synthesis, radiolabeling and evaluation of new PET ligands for metabotropic glutamate subtype 5 receptors. Nucl. Med. Biol., 32, 631640.
  • Yu, X., Wadghiri, Y.Z., Sanes, D.H. & Turnbull, D.H. (2005b) In vivo auditory brain mapping in mice with Mn-enhanced MRI. Nat. Neurosci., 8, 961968.